Literature DB >> 8143856

Cloning and functional characterization of the human 5-HT2B serotonin receptor.

K Schmuck1, C Ullmer, P Engels, H Lübbert.   

Abstract

Recently, we have reported the cloning of the rat 5-HT2B receptor cDNA. This receptor is particularly interesting since it may be involved in diseases such as migraine. Here, we describe the isolation of a human 5-HT2B receptor clone from a cDNA library derived from SH-SY5Y cells. Although the receptor sequence was only 80% homologous to the rat sequence, the exon-intron distribution was conserved between the two species. In the human body, the receptor mRNA was detected in most peripheral organs. Only low expression levels were found in the brain. After expression in HEK 293 cells, activation of the receptor stimulated the production of phosphatidylinositol. The pharmacology of this functional response correlated well with that of the rodent receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8143856     DOI: 10.1016/0014-5793(94)80590-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia.

Authors:  J Erdmann; D Shimron-Abarbanell; M Rietschel; M Albus; W Maier; J Körner; B Bondy; K Chen; J C Shih; M Knapp; P Propping; M M Nöthen
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

2.  RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist.

Authors:  D W Bonhaus; L A Flippin; R J Greenhouse; S Jaime; C Rocha; M Dawson; K Van Natta; L K Chang; T Pulido-Rios; A Webber; E Leung; R M Eglen; G R Martin
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 3.  Structure and function of serotonin G protein-coupled receptors.

Authors:  John D McCorvy; Bryan L Roth
Journal:  Pharmacol Ther       Date:  2015-01-17       Impact factor: 12.310

4.  Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.

Authors:  Loredana Riganti; Cosetta Matteoni; Silvia Di Angelantonio; Andrea Nistri; Annalisa Gaimarri; Fabio Sparatore; Caterina Canu-Boido; Francesco Clementi; Cecilia Gotti
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

5.  Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones.

Authors:  Alice M Holohean; John C Hackman
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

6.  Serotonin2A receptor binding potential in people with aggressive and violent behaviour.

Authors:  Jeffrey H Meyer; Alan A Wilson; Pablo Rusjan; Michael Clark; Sylvain Houle; Scott Woodside; John Arrowood; Krystle Martin; Michael Colleton
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

7.  Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment.

Authors:  M J Enguix; L Sánchez; M Villazón; J Brea; H Tristán; H J Caruncho; M I Cadavid; M I Loza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-12       Impact factor: 3.000

8.  In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties.

Authors:  G A Kennett; M D Wood; F Bright; J Cilia; D C Piper; T Gager; D Thomas; G S Baxter; I T Forbes; P Ham; T P Blackburn
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

Review 9.  Predictive in silico studies of human 5-hydroxytryptamine receptor subtype 2B (5-HT2B) and valvular heart disease.

Authors:  Terry-Elinor Reid; Krishna Kumar; Xiang Simon Wang
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

10.  Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505.

Authors:  Sandor Kantor; Rita Jakus; Brigitta Balogh; Anita Benko; Gyorgy Bagdy
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.